Your browser doesn't support javascript.
loading
The cost-effectiveness of HIV pre-exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in Brazil.
Luz, Paula M; Osher, Benjamin; Grinsztejn, Beatriz; Maclean, Rachel L; Losina, Elena; Stern, Madeline E; Struchiner, Claudio J; Parker, Robert A; Freedberg, Kenneth A; Mesquita, Fabio; Walensky, Rochelle P; Veloso, Valdilea G; Paltiel, A David.
Afiliação
  • Luz PM; The Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
  • Osher B; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA.
  • Grinsztejn B; Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Maclean RL; The Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
  • Losina E; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA.
  • Stern ME; Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Struchiner CJ; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA.
  • Parker RA; Harvard University Center for AIDS Research, Harvard Medical School, Boston, MA, USA.
  • Freedberg KA; Department of Orthopedic Surgery, Brigham and Women's Hospital, Boston, MA, USA.
  • Mesquita F; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
  • Walensky RP; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA.
  • Veloso VG; Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Paltiel AD; The Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
J Int AIDS Soc ; 21(3): e25096, 2018 03.
Article em En | MEDLINE | ID: mdl-29603888
INTRODUCTION: Men who have sex with men (MSM) and transgender women (TGW) in Brazil experience high rates of HIV infection. We examined the clinical and economic outcomes of implementing a pre-exposure prophylaxis (PrEP) programme in these populations. METHODS: We used the Cost-Effectiveness of Preventing AIDS Complications (CEPAC)-International model of HIV prevention and treatment to evaluate two strategies: the current standard of care (SOC) in Brazil, including universal ART access (No PrEP strategy); and the current SOC plus daily tenofovir/emtracitabine PrEP (PrEP strategy) until age 50. Mean age (31 years, SD 8.4 years), age-stratified annual HIV incidence (age ≤ 40 years: 4.3/100 PY; age > 40 years: 1.0/100 PY), PrEP effectiveness (43% HIV incidence reduction) and PrEP drug costs ($23/month) were from Brazil-based sources. The analysis focused on direct medical costs of HIV care. We measured the comparative value of PrEP in 2015 United States dollars (USD) per year of life saved (YLS). Willingness-to-pay threshold was based on Brazil's annual per capita gross domestic product (GDP; 2015: $8540 USD). RESULTS: Lifetime HIV infection risk among high-risk MSM and TGW was 50.5% with No PrEP and decreased to 40.1% with PrEP. PrEP increased per-person undiscounted (discounted) life expectancy from 36.8 (20.7) years to 41.0 (22.4) years and lifetime discounted HIV-related medical costs from $4100 to $8420, which led to an incremental cost-effectiveness ratio (ICER) of $2530/YLS. PrEP remained cost-effective (<1x GDP) under plausible variation in key parameters, including PrEP effectiveness and cost, initial cohort age and HIV testing frequency on/off PrEP. CONCLUSION: Daily tenofovir/emtracitabine PrEP among MSM and TGW at high risk of HIV infection in Brazil would increase life expectancy and be highly cost-effective.
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Homossexualidade Masculina / Fármacos Anti-HIV / Pessoas Transgênero / Profilaxia Pré-Exposição Tipo de estudo: Etiology_studies / Health_economic_evaluation / Risk_factors_studies Aspecto: Patient_preference Limite: Adult / Female / Humans / Male País/Região como assunto: America do sul / Brasil Idioma: En Revista: J Int AIDS Soc Assunto da revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Brasil País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Homossexualidade Masculina / Fármacos Anti-HIV / Pessoas Transgênero / Profilaxia Pré-Exposição Tipo de estudo: Etiology_studies / Health_economic_evaluation / Risk_factors_studies Aspecto: Patient_preference Limite: Adult / Female / Humans / Male País/Região como assunto: America do sul / Brasil Idioma: En Revista: J Int AIDS Soc Assunto da revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Brasil País de publicação: Suíça